openPR Logo
Press release

SMI Surgery Guidance interfaces Haag Streit LENSTARS

03-22-2011 06:23 PM CET | Health & Medicine

Press release from: SensoMotoric Instruments GmbH

SMI Surgery Guidance for IOL now provides registration link to Haag Streit LENSTAR LS900 biometry device.

Haag Streit AG (Switzerland) and SensoMotoric Instruments GmbH (SMI, Germany) present the SMI Surgery Guidance solution with registration capabilities for Haag Streit LENSTAR LS900 image data at the ASCRS in San Diego, USA (25 – 29th March 2011). With the registration link to SMI Surgery Guidance surgeons are able to determine automatically and in real-time the orientation of the eye under the surgery microscope relative to the LENSTAR LS900 measurement.

Launched at the ESCRS 2010, the SMI Surgery Guidance solution supports the precise orientation of toric IOL, the accurate centering of multifocal IOL, the exact position of incisions and LRIs and the centering and sizing of capsulorhexis. The registration of the surgery microscope live view to the LENSTAR LS900 reference image is performed fully automatic at the SMI Surgery Pilot without the use of manual markers. During the surgery the corresponding positioning and alignment overlays are superimposed on the camera live image at the computer screen and are injected into binoculars of the microscope (e.g. into the Moeller-Wedel Hi R 900) to intra-operatively support the surgeon with all important data directly and visually.

Dr. Oliver Kersting, Head of SMI’s Ophthalmic Systems business division says: “The Haag Streit LENSTAR is the first third party diagnostic device expanding the basis of the SMI Surgery Guidance platform. With the LENSTAR LS900 link to SMI Surgery Guidance the intra-surgery positioning of advanced technology lenses and incisions integrates seamlessly into the modern diagnostic and surgery process - for every patient and without extra effort.”

SensoMotoric Instruments GmbH (SMI) is the world leader in ophthalmic eye tracking solutions. SMI provides eye & gaze tracking systems, OEM and medical solutions for a wide range of applications such as ophthalmology, neurology, psychology, ergonomics and usability. SMI serves customers around the globe from offices in Teltow, near Berlin, Germany and Boston, USA, backed by a network of trusted local partners in many countries.

More information about SMI Surgery Guidance at www.surgery-guidance.com
and SensoMotoric Instruments GmbH at www.smivision.com

SensoMotoric Instruments GmbH
Warthestrasse 21
14513 Teltow
Germany

Contact:
Chen Weng
Clinical Marketing Manager

Phone:+49 (0)3328 3955-54
Fax: +49 (0)3328 3955-99
WEB: http://www.surgery-guidance.com
E-Mail: chen.weng@smi.de

Geschäftsführer / Managing Director: Eberhard Schmidt (Dipl. Ing., MBA)
Amtsgericht Potsdam HRB 22447 P; VAT-No.: DE 26650 8899

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMI Surgery Guidance interfaces Haag Streit LENSTARS here

News-ID: 167667 • Views: 2319

More Releases from SensoMotoric Instruments GmbH

POSITION PERFECTLY: 2000 SURGERIES PERFORMED WITH SMI SURGERY GUIDANCE™
SMI Surgery Guidance™ Solution is Mature and Complete From Pre-Op Diagnostics to Post-Op Assessment SensoMotoric Instruments GmbH (SMI), the established leader in eye tracking solutions for refractive laser surgery, exhibits the latest version of its Surgery Guidance Solution at the annual congress of the European Society of Cataract and Refractive Surgeons – ESCRS in Vienna, September 17th – 20th. The SMI Surgery Guidance™ solution allows surgeons to position perfectly cataract
IOL Surgery: Leica Microscopes integrated with SMI Surgery Guidance
Leica ophthalmic microscopes are now compatible with the SMI Surgery Guidance Solution for IOL surgery. Leica Microsystems AG (Leica, Switzerland) and SensoMotoric Instruments GmbH (SMI, Germany) present for the first time the SMI Surgery Guidance Solution integrated with a Leica ophthalmic microscope at the American Society of Cataract and Refractive Surgery (ASCRS) meeting, 25 – 29th March 2011 in San Diego, USA. This integration allows users of Leica ophthalmic microscopes (e.g.
Study dynamic content with SMI Experiment SuiteTM 360°- new methodologies for e …
The latest software release of SMI Experiment SuiteTM 360° sets a new standard for eye tracking studies on dynamic web content and merges objective visual attention data with new methodologies like task-based studies and enhanced multimedia RTA Quality and efficiency rise to a new level for eye tracking studies on dynamic web content, brochures and videos or other print and dynamic marketing material with release 3.0 of SMI Experiment

All 4 Releases


More Releases for SMI

SMi Presents the 16th Annual Conference: Parallel Trade 2022
SMi Presents the 16th Annual Conference: Parallel Trade 2022 Conference Date: 21st – 22nd March 2022 Workshop date: 23rd March 2022 Website: www.parallel-trade.com/ Navigating the challenges and legal landscapes of parallel trade SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together
Soft Mist Inhalers (SMI) Market 2021 | Detailed Report
Soft Mist Inhalers (SMI) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Soft Mist Inhalers (SMI) Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4943854 The report provides a comprehensive analysis of company profiles listed below: - 3M - Hovione -
Agenda released for SMi Group’s Controlled Release Delivery 2018
Building on the success of previous events, SMi has announced the return of its 15th annual Controlled Release Delivery, taking place on 21st and 22nd March in London, UK. An industry-leading show, the conference has been running for 15 years - a testament of how vital this particular focus is to the biotech and pharma sector. As physicians and scientists continue to find strategies to assist in simplifying treatment schedules for
SMI Eye Tracking Strengthens Scientific Profile
Neuropsychologist Dr. Ingmar Gutberlet appointed as new Director of Sales & Marketing at eye tracking specialist SensoMotoric Instruments (SMI) SensoMotoric Instruments (SMI), for more than 20 years a worldwide leader in eye tracking technology, appointed Dr. Ingmar Gutberlet as its Director of Sales & Marketing starting August 2012. With Dr. Gutberlet on the team, SMI further strengthens its scientific profile and its knowledge on the integration of eye tracking with
SMI Launches Eye Tracking Publications Database
Testimony to Reputation and Support of Future Research For 20 years, SMI Eye Tracking Solutions are successfully used in research projects and cited in numerous scientific publications. SMI`s new “Eye Tracking Publications Database" is a compilation of customers` experience and testimony to SMI`s reputation in a variety of application fields. The new database intends to provide a quick overview of relevant work conducted with SMI eye tracking solutions and to encourage
IOL Surgery: Leica Microscopes integrated with SMI Surgery Guidance
Leica ophthalmic microscopes are now compatible with the SMI Surgery Guidance Solution for IOL surgery. Leica Microsystems AG (Leica, Switzerland) and SensoMotoric Instruments GmbH (SMI, Germany) present for the first time the SMI Surgery Guidance Solution integrated with a Leica ophthalmic microscope at the American Society of Cataract and Refractive Surgery (ASCRS) meeting, 25 – 29th March 2011 in San Diego, USA. This integration allows users of Leica ophthalmic microscopes (e.g.